References
- SultanIQaddoumiIYaserSRodriguez-GalindoCFerrariAComparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patientsJ Clin Oncol200927203391339719398574
- vonMMRandallRLBenjaminRSSoft tissue sarcoma, version 2.2018J Natl Compr Canc Netw201816553656329752328
- AthbunRCLockhartSMStephensJRRhabdomyosarcoma in adults: new perspectives on therapyCurr Treat Options Oncol2015166342
- BrennanMFAlektiarKMMakiRGCancer: Principles & Practice of OncologyNew YorkLippincott Williams & Wilkins2011
- Limaverde-SousaGSternbergCFerreiraCGAntiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agentsCancer Treat Rev201440454855724360358
- FolkmanJRole of angiogenesis in tumor growth and metastasisSemin Oncol2002296 Suppl 161518
- GeeMFTsuchidaREichler-JonssonCVascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acidOncogene200524548025803716116481
- SchiavettiAMcdowellHPContiLVascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcomaPediatr Blood Cancer201259462763022231858
- GantiRSkapekSXZhangJExpression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcomaMod Pathol20061991213122016729016
- CroseLESLinardicCMReceptor tyrosine kinases as therapeutic targets in rhabdomyosarcomaSarcoma20102011714X1357
- XingPZhangJYanZRecombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IVOncotarget2017822367163672727888623
- TengCLiLIShenWPleural synovial sarcoma patient treated with combined chemotherapy and Endostar, plus sunitinib maintenance therapy: a case report and review of the literatureOncol Lett20151021141114426622640
- ZhangLPLiaoXYXuYMEfficacy and safety of Endostar® combined with chemotherapy in patients with advanced soft tissue sarcomasAsian Pac J Cancer Prev20131474255425923991986
- RuymannFBThe development of VAC chemotherapy in rhabdomyosarcoma: what does one do for an encore?Curr Oncol Rep20035650550914521810
- OberlinOReyALydenEPrognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groupsJ Clin Oncol200826142384238918467730
- ZhanXKZhangSCaoBWClinicopathological characteristics and treatment outcomes of Chinese patients with genitourinary embryonal rhabdomyosarcomaWorld J Surg Oncol201513119026018798
- KojimaYHashimotoKAndoMClinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapyJ Cancer Res Clin Oncol201213871249125722441933
- LiuZWZhangXQHouGLPrimary adult intratesticular rhabdomyosarcoma: results of the treatment of six casesInt J Urol201118217117421272089